10-69180461-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000359655.9(SUPV3L1):āc.170A>Gā(p.Lys57Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,614,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000359655.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUPV3L1 | NM_003171.5 | c.170A>G | p.Lys57Arg | missense_variant | 1/15 | ENST00000359655.9 | NP_003162.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUPV3L1 | ENST00000359655.9 | c.170A>G | p.Lys57Arg | missense_variant | 1/15 | 1 | NM_003171.5 | ENSP00000352678 | P1 | |
SUPV3L1 | ENST00000471069.5 | n.212A>G | non_coding_transcript_exon_variant | 1/6 | 1 | |||||
SUPV3L1 | ENST00000422378.1 | c.170A>G | p.Lys57Arg | missense_variant | 1/6 | 5 | ENSP00000409072 | |||
SUPV3L1 | ENST00000483572.5 | n.181A>G | non_coding_transcript_exon_variant | 1/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251338Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135876
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727244
GnomAD4 genome AF: 0.000237 AC: 36AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.170A>G (p.K57R) alteration is located in exon 1 (coding exon 1) of the SUPV3L1 gene. This alteration results from a A to G substitution at nucleotide position 170, causing the lysine (K) at amino acid position 57 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at